![Layton Patrick Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Layton Patrick Mills is the founder.
Founded CannPal Animal Therapeutics Ltd. in 2016, serving as Chief Executive Officer, Director & MD.
Former job at AusCann Group Holdings Ltd. as Chief Executive Officer from 2021 to 2022.
Former job at Argent BioPharma Ltd. as Non-Executive Director from 2023 to 2025.
Postes actifs de Layton Patrick Mills
| Sociétés | Poste | Début |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Fondateur | 03/06/2016 |
Anciens postes connus de Layton Patrick Mills
| Sociétés | Poste | Fin |
|---|---|---|
| ARGENT BIOPHARMA LIMITED | Directeur/Membre du Conseil | 05/02/2025 |
| AUSCANN GROUP HLDGS | Directeur Général | 13/09/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Argent BioPharma Ltd.
 Argent BioPharma Ltd. Pharmaceuticals: OtherHealth Technology Develops phytomedicine products | Health Technology |
AusCann Group Holdings Ltd.
 AusCann Group Holdings Ltd. BiotechnologyHealth Technology Engages in development and commercialization of cannabinoid-derived therapeutic products | Health Technology |
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals & nutraceutical products for dogs | Health Technology |
